PeptideDB

SARS-CoV-2 3CLpro-IN-28 2603242-35-7

SARS-CoV-2 3CLpro-IN-28 2603242-35-7

CAS No.: 2603242-35-7

SARS-CoV-2 3CLpro-IN-28 (Compound 19) is an inhibitor of SARS-CoV-2 3CLpro with IC50 of 0.018 μM.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

SARS-CoV-2 3CLpro-IN-28 (Compound 19) is an inhibitor of SARS-CoV-2 3CLpro with IC50 of 0.018 μM.

Physicochemical Properties


Molecular Formula C27H18CL2N4O4
Molecular Weight 533.36
CAS # 2603242-35-7
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CLpro inhibitors through validated structure-based drug design strategies. Heliyon. 2024 Nov 15;10(23):e40404.


Solubility Data


Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.8749 mL 9.3745 mL 18.7491 mL
5 mM 0.3750 mL 1.8749 mL 3.7498 mL
10 mM 0.1875 mL 0.9375 mL 1.8749 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.